acetylshikonin has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amici, A; Buccioni, M; Cui, L; Dall'Acqua, S; Falconi, M; Galeazzi, R; Giangrossi, M; Iannarelli, R; Laudadio, E; Maggi, F; Marchini, C; Marucci, G; Navia, AM; Pucciarelli, S; Serini, L; Sut, S; Tomassoni, D; Wang, J | 1 |
1 other study(ies) available for acetylshikonin and Breast Neoplasms
| Article | Year |
|---|---|
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Folic Acid Antagonists; Humans; Lithospermum; Mice, Transgenic; Plant Roots; Receptor, ErbB-2; Signal Transduction; Tetrahydrofolate Dehydrogenase; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |